Patient Files: Malaria
Laurie Griffiths contracted malaria while travelling in Africa. He tells PharmaTimes his story
PharmaTimes Magazine
PharmaTimes is the UK's leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.
PharmaTimes print and digital versions have a total circulation of 23,184, reaching right across the industry into every company and every function. What's more, our circulation includes 8,000 NHS healthcare professionals: chief pharmacists, medicines management and primary care commissioners.
Click to subscribe to PharmaTimes in paper or print, or to sign up for our industry-leading daily and weekly news elerts.
You can read the latest issue as well as our extensive archive below or get in touch with the editorial or sales team.
Magazine highlights
View more from the latest edition
Company focus: bluebird bio
Andrew Obenshain, senior vice president and head of Europe at bluebird bio, introduces the company and discusses the challenges and opportunities of gene therapy
A collaborative approach
The viability and value of continuous bioprocessing is now irrefutable, but pharma will need to work with regulators and get the right data to overcome any roadblocks
A roadmap to navigate telehealth
The business potential of telehealth is tremendous in a world in which quality and access to care are of growing importance, but the new challenges it poses cannot be addressed within the borders of our traditional areas of the law
Early access
Lorenzo D’Angelo on strategies for implementing successful pre-launch access programmes
Flight of the navigators
Sales in pharma is a frequently changing canvass. Its leveraging of technology has triggered new, bold approaches, while also upholding a fine tradition of individuality among its multifarious and talented workforce. Finding the most compelling mix of human attributes and digital dynamism holds the key to sustained pharma sales success – indeed, it is an industry artform
Drugging the ‘undruggables’
Mani Krishnan on the renaissance of oligonucleotide therapies
GSK and the trouble with vaccines in Africa
Ana Nicholls on Malawi's new anti-malaria vaccination programme, and GlaxoSmithKline's wider position in the field
